0000914190-21-000288.txt : 20210823
0000914190-21-000288.hdr.sgml : 20210823
20210823161556
ACCESSION NUMBER: 0000914190-21-000288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210819
FILED AS OF DATE: 20210823
DATE AS OF CHANGE: 20210823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Furlow Brenda S.
CENTRAL INDEX KEY: 0001443851
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 211197024
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-08-19
0000842023
BIO-TECHNE Corp
TECH
0001443851
Furlow Brenda S.
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
1
0
0
SVP - General Counsel
Common Stock
2021-08-19
4
M
0
3538
106.59
A
10359
D
Common Stock
2021-08-19
4
M
0
799
125.05
A
11158
D
Common Stock
2021-08-19
4
S
0
1100
473.0823
D
10058
D
Common Stock
2021-08-19
4
S
0
1838
474.1168
D
8220
D
Common Stock
2021-08-19
4
S
0
600
475.0536
D
7620
D
Stock Options (Right to Buy)
108.49
2022-08-07
Common Stock
921
921
D
Stock Options (Right to Buy)
106.59
2021-08-19
4
M
0
3538
0
D
2023-08-18
Common Stock
3538
0
D
Stock Options (Right to Buy)
125.05
2021-08-19
4
M
0
799
0
D
2024-08-09
Common Stock
799
8704
D
Stock Options (Right to Buy)
125.05
2024-08-09
Common Stock
12670
12670
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
7339
7339
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
9786
9786
D
Restricted Stock Units
Common Stock
1969
1969
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
9968
9968
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
13290
13290
D
Restricted Stock Units
Common Stock
1679
1679
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
7492
7492
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
9990
9990
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
8325
8325
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
8325.0
8325.0
D
Stock Options (Right to Buy)
372.44
2022-08-31
2028-03-01
Common Stock
10997
10997
D
Restricted Stock Units
Common Stock
1167
1167
D
Stock Options (Right to Buy)
481.82
2028-08-06
Common Stock
4560
4560
D
Stock Options (Right to Buy)
481.82
2028-08-06
Common Stock
6080
6080
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $472.50 to $473.46, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $473.6350 to $474.57, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $474.79 to 475.5250, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Fully exercisable.
Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022.
Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 2,498 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,497 shares vest on each of 8/5/2023 and 8/5/2024.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
/s/ Andrew Nick as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed.
2021-08-23